Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia

Yoshikane Izawa, Shinichi Takahashi, Norihiro Suzuki

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Peroxisome proliferator-activated receptor γ (PPARγ) agonists play important roles in the regulation of energy metabolism and are widely used for patients with type 2 diabetes. PPARγagonists reportedly reduce plasma glucose levels by recruiting glucose transporters to the cellular membrane, resulting in the enhanced uptake of glucose. However, only a limited number of studies have examined the effect of PPARγ on cerebral glucose metabolism. In the present study, we examined the effects of a PPARγ agonist, pioglitazone, on glucose metabolism in cultured rat neurons and astroglia. Cultures of neurons or astroglia were prepared from Sprague-Dawley rats. The cells were treated with pioglitazone (0-50 μM) for 48 hours prior to assay. Lactate released into the culture medium (an index of glycolytic glucose metabolism) and [U- 14C]lactate or [1- 14C]pyruvate oxidation (an index of oxidative glucose metabolism) were measured. In addition, the production of cellular reactive oxygen species (ROS) was determined utilizing an H2DCFDA assay. Forty-eight hours of exposure to pioglitazone (0.5 and 5 μM) resulted in dose-dependent increases in lactate release into the astroglial culture medium but not into the neuronal culture medium. [U-14C]lactate oxidation and [1- 14C]pyruvate oxidation were enhanced in the neurons, but not in the astroglia. These actions of pioglitazone were not inhibited by 2-chloro-5-nitrobenzanilide (GW9662), a potent antagonist of PPARγ, and were not mimicked by N-(2-benzoylphenyl)-O-[2-(methyl-2- pyridinylamino)ethyl]-L-tyrosine (GW1929), a non-thiazolidinedione PPARγ agonist. Pioglitazone enhanced aerobic glycolysis and lactate release in astroglia, while the oxidative metabolism of glucose, but not glycolysis, was augmented in neurons without increasing ROS production. These results indicate that pioglitazone may enhance the efficiency of glucose metabolism in the brain.

Original languageEnglish
Pages (from-to)64-73
Number of pages10
JournalBrain Research
Volume1305
DOIs
Publication statusPublished - 2009 Dec 11

Fingerprint

pioglitazone
Pyruvic Acid
Astrocytes
Lactic Acid
Peroxisome Proliferator-Activated Receptors
Neurons
Glucose
Culture Media
Glycolysis
Reactive Oxygen Species
Facilitative Glucose Transport Proteins
Type 2 Diabetes Mellitus
Energy Metabolism

Keywords

  • Astrocyte
  • Glucose metabolism
  • PDH
  • PPARγ agonist
  • ROS

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia. / Izawa, Yoshikane; Takahashi, Shinichi; Suzuki, Norihiro.

In: Brain Research, Vol. 1305, 11.12.2009, p. 64-73.

Research output: Contribution to journalArticle

@article{b00c9f7a592c4f168d7579a4da51ea87,
title = "Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia",
abstract = "Peroxisome proliferator-activated receptor γ (PPARγ) agonists play important roles in the regulation of energy metabolism and are widely used for patients with type 2 diabetes. PPARγagonists reportedly reduce plasma glucose levels by recruiting glucose transporters to the cellular membrane, resulting in the enhanced uptake of glucose. However, only a limited number of studies have examined the effect of PPARγ on cerebral glucose metabolism. In the present study, we examined the effects of a PPARγ agonist, pioglitazone, on glucose metabolism in cultured rat neurons and astroglia. Cultures of neurons or astroglia were prepared from Sprague-Dawley rats. The cells were treated with pioglitazone (0-50 μM) for 48 hours prior to assay. Lactate released into the culture medium (an index of glycolytic glucose metabolism) and [U- 14C]lactate or [1- 14C]pyruvate oxidation (an index of oxidative glucose metabolism) were measured. In addition, the production of cellular reactive oxygen species (ROS) was determined utilizing an H2DCFDA assay. Forty-eight hours of exposure to pioglitazone (0.5 and 5 μM) resulted in dose-dependent increases in lactate release into the astroglial culture medium but not into the neuronal culture medium. [U-14C]lactate oxidation and [1- 14C]pyruvate oxidation were enhanced in the neurons, but not in the astroglia. These actions of pioglitazone were not inhibited by 2-chloro-5-nitrobenzanilide (GW9662), a potent antagonist of PPARγ, and were not mimicked by N-(2-benzoylphenyl)-O-[2-(methyl-2- pyridinylamino)ethyl]-L-tyrosine (GW1929), a non-thiazolidinedione PPARγ agonist. Pioglitazone enhanced aerobic glycolysis and lactate release in astroglia, while the oxidative metabolism of glucose, but not glycolysis, was augmented in neurons without increasing ROS production. These results indicate that pioglitazone may enhance the efficiency of glucose metabolism in the brain.",
keywords = "Astrocyte, Glucose metabolism, PDH, PPARγ agonist, ROS",
author = "Yoshikane Izawa and Shinichi Takahashi and Norihiro Suzuki",
year = "2009",
month = "12",
day = "11",
doi = "10.1016/j.brainres.2009.09.098",
language = "English",
volume = "1305",
pages = "64--73",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia

AU - Izawa, Yoshikane

AU - Takahashi, Shinichi

AU - Suzuki, Norihiro

PY - 2009/12/11

Y1 - 2009/12/11

N2 - Peroxisome proliferator-activated receptor γ (PPARγ) agonists play important roles in the regulation of energy metabolism and are widely used for patients with type 2 diabetes. PPARγagonists reportedly reduce plasma glucose levels by recruiting glucose transporters to the cellular membrane, resulting in the enhanced uptake of glucose. However, only a limited number of studies have examined the effect of PPARγ on cerebral glucose metabolism. In the present study, we examined the effects of a PPARγ agonist, pioglitazone, on glucose metabolism in cultured rat neurons and astroglia. Cultures of neurons or astroglia were prepared from Sprague-Dawley rats. The cells were treated with pioglitazone (0-50 μM) for 48 hours prior to assay. Lactate released into the culture medium (an index of glycolytic glucose metabolism) and [U- 14C]lactate or [1- 14C]pyruvate oxidation (an index of oxidative glucose metabolism) were measured. In addition, the production of cellular reactive oxygen species (ROS) was determined utilizing an H2DCFDA assay. Forty-eight hours of exposure to pioglitazone (0.5 and 5 μM) resulted in dose-dependent increases in lactate release into the astroglial culture medium but not into the neuronal culture medium. [U-14C]lactate oxidation and [1- 14C]pyruvate oxidation were enhanced in the neurons, but not in the astroglia. These actions of pioglitazone were not inhibited by 2-chloro-5-nitrobenzanilide (GW9662), a potent antagonist of PPARγ, and were not mimicked by N-(2-benzoylphenyl)-O-[2-(methyl-2- pyridinylamino)ethyl]-L-tyrosine (GW1929), a non-thiazolidinedione PPARγ agonist. Pioglitazone enhanced aerobic glycolysis and lactate release in astroglia, while the oxidative metabolism of glucose, but not glycolysis, was augmented in neurons without increasing ROS production. These results indicate that pioglitazone may enhance the efficiency of glucose metabolism in the brain.

AB - Peroxisome proliferator-activated receptor γ (PPARγ) agonists play important roles in the regulation of energy metabolism and are widely used for patients with type 2 diabetes. PPARγagonists reportedly reduce plasma glucose levels by recruiting glucose transporters to the cellular membrane, resulting in the enhanced uptake of glucose. However, only a limited number of studies have examined the effect of PPARγ on cerebral glucose metabolism. In the present study, we examined the effects of a PPARγ agonist, pioglitazone, on glucose metabolism in cultured rat neurons and astroglia. Cultures of neurons or astroglia were prepared from Sprague-Dawley rats. The cells were treated with pioglitazone (0-50 μM) for 48 hours prior to assay. Lactate released into the culture medium (an index of glycolytic glucose metabolism) and [U- 14C]lactate or [1- 14C]pyruvate oxidation (an index of oxidative glucose metabolism) were measured. In addition, the production of cellular reactive oxygen species (ROS) was determined utilizing an H2DCFDA assay. Forty-eight hours of exposure to pioglitazone (0.5 and 5 μM) resulted in dose-dependent increases in lactate release into the astroglial culture medium but not into the neuronal culture medium. [U-14C]lactate oxidation and [1- 14C]pyruvate oxidation were enhanced in the neurons, but not in the astroglia. These actions of pioglitazone were not inhibited by 2-chloro-5-nitrobenzanilide (GW9662), a potent antagonist of PPARγ, and were not mimicked by N-(2-benzoylphenyl)-O-[2-(methyl-2- pyridinylamino)ethyl]-L-tyrosine (GW1929), a non-thiazolidinedione PPARγ agonist. Pioglitazone enhanced aerobic glycolysis and lactate release in astroglia, while the oxidative metabolism of glucose, but not glycolysis, was augmented in neurons without increasing ROS production. These results indicate that pioglitazone may enhance the efficiency of glucose metabolism in the brain.

KW - Astrocyte

KW - Glucose metabolism

KW - PDH

KW - PPARγ agonist

KW - ROS

UR - http://www.scopus.com/inward/record.url?scp=73949134015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73949134015&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2009.09.098

DO - 10.1016/j.brainres.2009.09.098

M3 - Article

C2 - 19800324

AN - SCOPUS:73949134015

VL - 1305

SP - 64

EP - 73

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -